AXON Neuroscience’s investigational AADvac1 vaccine against tau protein, a hallmark of Alzheimer’s disease, was found safe and effective at…
Articles by Patricia Inacio, PhD
A new 3D model using human cells grown on a chip can mimic what happens in the brain during Alzheimer’s…
A diet rich in phosphatidylcholine, a form of the choline found in foods like eggs and meat, was linked to a…
Alkahest’s experimental blood-derived protein GRF6019 helps maintain cognition and function in mild to moderate Alzheimer’s disease patients, results…
Blood levels of certain molecules— metabolites and amino acids — may help to identify people with Alzheimer’s disease who are more…
AC Immune is launching a Phase 1b/2a clinical trial to evaluate an investigational anti-tau vaccine called ACI-35.030Â as a…
AZTherapies has completed enrollment for its Phase 3 COGNITE trial, testing the safety and efficacy of its investigational…
A mutation in a gene linked to familial Alzheimer’s disease promotes the disease by reducing the points of…
Alzheimer’s disease patients carrying a gene found only in humans, called CHRFAM7A, are less responsive to cholinesterase inhibitors, a…
Following the approval of its investigational new drug (IND) application by the U.S. Food and Drug Administration (FDA),…